| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 10/08/2008 | CN100424085C Total alkaloid of xiatianwu (a Chinese medicinal material), its preparation method and application |
| 10/08/2008 | CN100423777C Glycoprotein compositions |
| 10/08/2008 | CN100423755C Chinese medicine preparation for treating bone fracture and preparing method thereof |
| 10/08/2008 | CN100423740C Oral and externally-applied Chinese medicinal preparation for treating osteoproliferation and its production |
| 10/08/2008 | CN100423652C Natural ª-carotene microcapsule and method for making same |
| 10/07/2008 | US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 10/07/2008 | US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying |
| 10/07/2008 | US7432361 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis |
| 10/07/2008 | US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944 |
| 10/07/2008 | US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors |
| 10/07/2008 | US7432286 Pharmaceutically active sulfonyl hydrazide derivatives |
| 10/07/2008 | US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 10/07/2008 | US7432270 N-aroyl cyclic amines |
| 10/07/2008 | US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 10/07/2008 | US7432240 Fumaric acid amides |
| 10/07/2008 | US7432049 Compositions and methods relating to osteoarthritis |
| 10/07/2008 | US7431922 Bioadhesive directed somatic cell therapy |
| 10/07/2008 | CA2435946C Piperidine derivatives as neurokinin 1 antagonists |
| 10/07/2008 | CA2433772C Pyrimidine matrix metalloproteinase inhibitors |
| 10/07/2008 | CA2427573C Indole derivatives as pde5-inhibitors |
| 10/07/2008 | CA2416685C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 10/07/2008 | CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives |
| 10/07/2008 | CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants |
| 10/07/2008 | CA2366841C Tolperisone-containing pharmaceutical preparation for oral administration |
| 10/07/2008 | CA2362582C Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 10/07/2008 | CA2331461C Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 10/02/2008 | WO2008118711A2 Method of inhibiting complement activation with human anti-factor c3 antibodies and use thereof |
| 10/02/2008 | WO2008118454A2 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer |
| 10/02/2008 | WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 10/02/2008 | WO2008117814A1 Oral pharmaceutical preparation for colon-specific delivery |
| 10/02/2008 | WO2008117801A1 Composition for cartilage protection |
| 10/02/2008 | WO2008116816A1 Combination of cb2 ligand and paracetamol |
| 10/02/2008 | WO2008116809A1 Pharmaceutical compositions comprising a bisphosphonate and vitamin d |
| 10/02/2008 | WO2008116671A1 2,3,4,9-tetrahydro-1h-carbazoles |
| 10/02/2008 | WO2008057283A3 Use of resolvins for inhibition of bone loss |
| 10/02/2008 | WO2007093806A8 Dissolution aids for oral peptide delivery comprising a biguanide |
| 10/02/2008 | WO2007059209A3 Extract of dioscorea sp. and the medical uses thereof |
| 10/02/2008 | US20080242722 composition comprising a nitric oxide donating compound (e.g. 5,6-bis(nitrooxy)hexyl acetate) and cyclooxygenase-2 selective inhibitor; antiinflammatory, analgesic agent; to reduce the gastrointestinal toxicity caused by aspirin and COX-inhibitor therapy |
| 10/02/2008 | US20080242719 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders |
| 10/02/2008 | US20080242717 Methods for treating benign prostatic hyperplasia |
| 10/02/2008 | US20080242690 Methods and Compositions for Promoting Bone and Joint Health |
| 10/02/2008 | US20080242687 endothelin modulators/antagonists; reduced hepatoxicity; hypotensive agents; Deuterated Pyrimidine Derivatives like 4-tert-Butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-[2,2']bipyrimidinyl-4-yl]-benzenesulfonamide |
| 10/02/2008 | US20080242681 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors |
| 10/02/2008 | US20080242661 Novel compounds useful for the treatment of degenerative & inflammatory diseases |
| 10/02/2008 | US20080242652 Indole derivatives and their metal conjugates and uses thereof |
| 10/02/2008 | US20080242619 Peptidomimetics ; determine ability to bind to growth hormone secretagogue; ghrelin antagonist; appetite stimulation; dietetics ; weight maintenance; eating disorders |
| 10/02/2008 | US20080242599 Compositions and Methods for Increasing Osteoblast Cell Differentiation and Bone Generation |
| 10/02/2008 | US20080242591 Treating vascular malformation with nicotinic acetylcholine receptor (nAChR) antagonist; arthritis, cancer |
| 10/02/2008 | US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same |
| 10/02/2008 | US20080241960 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders |
| 10/02/2008 | US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders |
| 10/02/2008 | US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 10/02/2008 | US20080241283 Aqueous extracts of anoectochilus spp. kinsenoside-comprising pharmaceutical compositions useful for hepatoprotection and uses of the same |
| 10/02/2008 | US20080241277 Herbal formulation for the treatment of bone fractures and osseous defects |
| 10/02/2008 | US20080241250 In vivo bioreactors and methods of making and using same |
| 10/02/2008 | US20080241211 Carrier matrix having an osteoinductive agent selected from TGF- beta or a bone morphogenic protein, and an osteoinductive enhancer, preferably naringin, integrated therein; dentistry |
| 10/02/2008 | US20080241163 Tweak binding antibodies |
| 10/02/2008 | US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders |
| 10/02/2008 | US20080241129 Adipocyte secreted protein ccdc80 is a potent stimulator of bone formation |
| 10/02/2008 | US20080241108 Bone Morphogenic Protein Binding Peptide |
| 10/02/2008 | CA2684655A1 Oral pharmaceutical preparation for colon-specific delivery |
| 10/02/2008 | CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure |
| 10/01/2008 | EP1975162A1 Oxazolone derivative |
| 10/01/2008 | EP1975159A1 2,3,4,9-Tetrahydro-1H-carbazoles |
| 10/01/2008 | EP1973880A1 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 10/01/2008 | EP1773364B1 Nutritional compositions and methods for treating or preventing osteoporosis |
| 10/01/2008 | EP1372655B1 Cathepsin cysteine protease inhibitors |
| 10/01/2008 | CN101275136A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and DNAs encoding the same |
| 10/01/2008 | CN101274962A Antibodies against human IL-12 |
| 10/01/2008 | CN101274961A Recombinant human parathyroid hormone related protein |
| 10/01/2008 | CN101274094A Gubao tablets and technique for producing and preparing the same |
| 10/01/2008 | CN101274079A Dogskin plaster and technique of preparing the same |
| 10/01/2008 | CN101274060A Loins-strengthening and kidney-invigorating paste |
| 10/01/2008 | CN101274055A Medicament for fumigating rheumatic arthritis and rheumatoid arthritis |
| 10/01/2008 | CN101274049A Medicament for curing multiple traumas |
| 10/01/2008 | CN101274027A Oral medicament, hot compress powder for curing femoral head necrosis |
| 10/01/2008 | CN100422337C Process for producing 1,4-dihydoxy-2-naphthoic acid |
| 10/01/2008 | CN100422315C Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 10/01/2008 | CN100422173C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100422172C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100422168C Hesperetin derivant and preparation process thereof |
| 10/01/2008 | CN100422161C Hydroxymorpholinone derivative and medicinal use thereof |
| 10/01/2008 | CN100421703C Gout granules |
| 10/01/2008 | CN100421695C Plaster for treating femur head necrosis |
| 10/01/2008 | CN100421677C Use of stub-like bacillus prepn. or acellular stub-like bacillus prepn. |
| 10/01/2008 | CN100421667C Method for treating and preventing hyperparathyroidism |
| 09/30/2008 | US7429592 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
| 09/30/2008 | US7429591 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(2-Amino-6-chloro-phenyl)-piperazin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 09/30/2008 | US7429576 treatment for osteoporosis, hypercholesterolemia, hyperlipidemia, atherosclerosis, breast cancer, endometrial cancer, ovarian cancer and uterine cancer while minimizing undesirable side effects |
| 09/30/2008 | US7429568 Antidiabetic agents; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; hyperglycemia, obesity; 3-(6-O-ethoxycarbonyl- beta -D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole |
| 09/30/2008 | US7429488 Method for processing lipoaspirate cells |
| 09/30/2008 | CA2453646C 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 09/30/2008 | CA2355470C Benzoheterocycles and their use as mek inhibitors |
| 09/30/2008 | CA2338220C Substituted imidazoles having cytokine inhibitory activity |
| 09/30/2008 | CA2303848C Substituted anilides |
| 09/25/2008 | WO2008116133A1 Medication kits and formulations for preventing, treating or reducing secondary fractures after previous fracture |
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114817A1 Novel adenine compound |
| 09/25/2008 | WO2008114679A1 Bone metabolism ameliorating agent |
| 09/25/2008 | WO2008114536A1 Dehydroepiandrosterone production promoter and use thereof |